FIVE BELOW (FIVE)

US33829M1018 - Common Stock

106.08  -1.67 (-1.55%)

After market: 105.76 -0.32 (-0.3%)

Fundamental Rating

6

Taking everything into account, FIVE scores 6 out of 10 in our fundamental rating. FIVE was compared to 122 industry peers in the Specialty Retail industry. FIVE has an excellent financial health rating, but there are some minor concerns on its profitability. FIVE is valued quite expensive, but it does show an excellent growth. This makes FIVE very considerable for growth investing!



6

1. Profitability

1.1 Basic Checks

FIVE had positive earnings in the past year.
FIVE had a positive operating cash flow in the past year.
Each year in the past 5 years FIVE has been profitable.
Each year in the past 5 years FIVE had a positive operating cash flow.

1.2 Ratios

The Return On Assets of FIVE (6.41%) is better than 73.55% of its industry peers.
Looking at the Return On Equity, with a value of 16.61%, FIVE is in the better half of the industry, outperforming 75.21% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.85%, FIVE is doing good in the industry, outperforming 68.59% of the companies in the same industry.
FIVE had an Average Return On Invested Capital over the past 3 years of 11.55%. This is in line with the industry average of 12.03%.
Industry RankSector Rank
ROA 6.41%
ROE 16.61%
ROIC 7.85%
ROA(3y)8.44%
ROA(5y)7.92%
ROE(3y)21.03%
ROE(5y)20.02%
ROIC(3y)11.55%
ROIC(5y)10.28%

1.3 Margins

With an excellent Profit Margin value of 7.02%, FIVE belongs to the best of the industry, outperforming 84.30% of the companies in the same industry.
FIVE's Profit Margin has declined in the last couple of years.
FIVE has a better Operating Margin (9.04%) than 82.64% of its industry peers.
FIVE's Operating Margin has declined in the last couple of years.
FIVE has a Gross Margin (35.18%) which is in line with its industry peers.
FIVE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.04%
PM (TTM) 7.02%
GM 35.18%
OM growth 3Y8.83%
OM growth 5Y-2.03%
PM growth 3Y10.39%
PM growth 5Y-2.48%
GM growth 3Y2.49%
GM growth 5Y-0.25%

7

2. Health

2.1 Basic Checks

FIVE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for FIVE has been reduced compared to 1 year ago.
Compared to 5 years ago, FIVE has less shares outstanding
FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 3.14 indicates that FIVE is not in any danger for bankruptcy at the moment.
FIVE's Altman-Z score of 3.14 is fine compared to the rest of the industry. FIVE outperforms 69.42% of its industry peers.
There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.14
ROIC/WACC0.77
WACC10.25%

2.3 Liquidity

FIVE has a Current Ratio of 1.38. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.38, FIVE perfoms like the industry average, outperforming 50.41% of the companies in the same industry.
FIVE has a Quick Ratio of 1.38. This is a bad value and indicates that FIVE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FIVE (0.45) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.45

7

3. Growth

3.1 Past

FIVE shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.64%.
Measured over the past years, FIVE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.56% on average per year.
Looking at the last year, FIVE shows a quite strong growth in Revenue. The Revenue has grown by 14.32% in the last year.
The Revenue has been growing by 17.94% on average over the past years. This is quite good.
EPS 1Y (TTM)7.64%
EPS 3Y35.47%
EPS 5Y15.56%
EPS Q2Q%61.54%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y21.96%
Revenue growth 5Y17.94%
Sales Q2Q%14.57%

3.2 Future

Based on estimates for the next years, FIVE will show a very strong growth in Earnings Per Share. The EPS will grow by 25.19% on average per year.
FIVE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.34% yearly.
EPS Next Y-7.25%
EPS Next 2Y-1.28%
EPS Next 3Y3.46%
EPS Next 5Y25.19%
Revenue Next Year8.13%
Revenue Next 2Y9.17%
Revenue Next 3Y9.52%
Revenue Next 5Y16.34%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.36, which indicates a rather expensive current valuation of FIVE.
Based on the Price/Earnings ratio, FIVE is valued a bit cheaper than 66.12% of the companies in the same industry.
FIVE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
FIVE is valuated rather expensively with a Price/Forward Earnings ratio of 20.08.
Based on the Price/Forward Earnings ratio, FIVE is valued a bit cheaper than the industry average as 62.81% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, FIVE is valued at the same level.
Industry RankSector Rank
PE 20.36
Fwd PE 20.08

4.2 Price Multiples

FIVE's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as FIVE.
Industry RankSector Rank
P/FCF 58.44
EV/EBITDA 11.04

4.3 Compensation for Growth

The decent profitability rating of FIVE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.31
EPS Next 2Y-1.28%
EPS Next 3Y3.46%

0

5. Dividend

5.1 Amount

No dividends for FIVE!.
Industry RankSector Rank
Dividend Yield N/A

FIVE BELOW

NASDAQ:FIVE (12/20/2024, 8:11:31 PM)

After market: 105.76 -0.32 (-0.3%)

106.08

-1.67 (-1.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-04 2024-12-04/amc
Earnings (Next)N/A N/A
Inst Owners107.6%
Inst Owner Change-2.69%
Ins Owners1.66%
Ins Owner Change10.94%
Market Cap5.84B
Analysts70.97
Price Target107.69 (1.52%)
Short Float %7.12%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)70.91%
Min EPS beat(2)-2.24%
Max EPS beat(2)144.07%
EPS beat(4)1
Avg EPS beat(4)32.6%
Min EPS beat(4)-6.03%
Max EPS beat(4)144.07%
EPS beat(8)3
Avg EPS beat(8)17.61%
EPS beat(12)4
Avg EPS beat(12)19.23%
EPS beat(16)8
Avg EPS beat(16)19.37%
Revenue beat(2)1
Avg Revenue beat(2)1.49%
Min Revenue beat(2)-1.02%
Max Revenue beat(2)3.99%
Revenue beat(4)1
Avg Revenue beat(4)-1.09%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)3.99%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)2
Avg Revenue beat(12)-1.39%
Revenue beat(16)5
Avg Revenue beat(16)-0.43%
PT rev (1m)-1.29%
PT rev (3m)-2.34%
EPS NQ rev (1m)-12.26%
EPS NQ rev (3m)-12.26%
EPS NY rev (1m)7.54%
EPS NY rev (3m)7.87%
Revenue NQ rev (1m)-2.68%
Revenue NQ rev (3m)-2.68%
Revenue NY rev (1m)1.89%
Revenue NY rev (3m)2.02%
Valuation
Industry RankSector Rank
PE 20.36
Fwd PE 20.08
P/S 1.53
P/FCF 58.44
P/OCF 12.29
P/B 3.61
P/tB 3.61
EV/EBITDA 11.04
EPS(TTM)5.21
EY4.91%
EPS(NY)5.28
Fwd EY4.98%
FCF(TTM)1.82
FCFY1.71%
OCF(TTM)8.63
OCFY8.14%
SpS69.5
BVpS29.37
TBVpS29.37
PEG (NY)N/A
PEG (5Y)1.31
Profitability
Industry RankSector Rank
ROA 6.41%
ROE 16.61%
ROCE 10.44%
ROIC 7.85%
ROICexc 8.39%
ROICexgc 8.39%
OM 9.04%
PM (TTM) 7.02%
GM 35.18%
FCFM 2.61%
ROA(3y)8.44%
ROA(5y)7.92%
ROE(3y)21.03%
ROE(5y)20.02%
ROIC(3y)11.55%
ROIC(5y)10.28%
ROICexc(3y)13.55%
ROICexc(5y)12.25%
ROICexgc(3y)13.55%
ROICexgc(5y)12.25%
ROCE(3y)15.37%
ROCE(5y)13.68%
ROICexcg growth 3Y8.42%
ROICexcg growth 5Y-22.66%
ROICexc growth 3Y8.42%
ROICexc growth 5Y-22.66%
OM growth 3Y8.83%
OM growth 5Y-2.03%
PM growth 3Y10.39%
PM growth 5Y-2.48%
GM growth 3Y2.49%
GM growth 5Y-0.25%
F-Score6
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 235.8%
Cap/Sales 9.81%
Interest Coverage 250
Cash Conversion 94.12%
Profit Quality 37.21%
Current Ratio 1.38
Quick Ratio 0.45
Altman-Z 3.14
F-Score6
WACC10.25%
ROIC/WACC0.77
Cap/Depr(3y)278.25%
Cap/Depr(5y)301.93%
Cap/Sales(3y)9.24%
Cap/Sales(5y)9.88%
Profit Quality(3y)30.98%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.64%
EPS 3Y35.47%
EPS 5Y15.56%
EPS Q2Q%61.54%
EPS Next Y-7.25%
EPS Next 2Y-1.28%
EPS Next 3Y3.46%
EPS Next 5Y25.19%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y21.96%
Revenue growth 5Y17.94%
Sales Q2Q%14.57%
Revenue Next Year8.13%
Revenue Next 2Y9.17%
Revenue Next 3Y9.52%
Revenue Next 5Y16.34%
EBIT growth 1Y0.75%
EBIT growth 3Y32.73%
EBIT growth 5Y15.55%
EBIT Next Year22.42%
EBIT Next 3Y16.71%
EBIT Next 5Y24.8%
FCF growth 1Y210.47%
FCF growth 3Y-0.25%
FCF growth 5Y18.51%
OCF growth 1Y200.15%
OCF growth 3Y10.93%
OCF growth 5Y22.1%